Cargando…
Blood biomarkers for Alzheimer’s disease
Simon Lovestone discusses recent progress in the development of molecular biomarkers for the diagnosis and prognosis of Alzheimer’s disease.
Autor principal: | Lovestone, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254416/ https://www.ncbi.nlm.nih.gov/pubmed/25473432 http://dx.doi.org/10.1186/s13073-014-0065-7 |
Ejemplares similares
-
Policy for rare diseases
Publicado: (2023) -
Diagnostics for rare diseases
Publicado: (2023) -
Challenges in understanding common disease
por: Visscher, Peter M.
Publicado: (2017) -
Individualized ASO therapy for rare diseases
Publicado: (2023) -
The circadian clock system’s influence in health and disease
por: Bass, Joseph T.
Publicado: (2017)